ABSTRACT
El objetivo de este trabajo es lograr sistematizar los cuidados de enfermeria al paciente con indicacion de angioplastia transluminal coronaria percutanea en el servicio de Hemodinamia del Sanatorio Allende.
Subject(s)
Humans , Angioplasty , Nursing Care , Postoperative Care , Preoperative CareABSTRACT
Prevención cardiovascular. Cardiopatía isquémica. Arritmias y sincope. Valvulopatías. Enfermedad Vascular. Insuficiencia. Cardíaca y miocardiopatías
Subject(s)
Humans , Cardiology , Cardiovascular Diseases , Clinical Trials as Topic , Cardiovascular Diseases/prevention & control , Chagas Cardiomyopathy , Heart Diseases , Pregnancy Complications, CardiovascularABSTRACT
PURPOSE: To evaluate the immediate and long term results of percutaneous transluminal coronary balloon angioplasty (PTCA) in patients over 80 years old. METHODS: From 1/1/89 to 6/31/95, 97 patients with 80 years of age or older were submitted to PTCA and were divided into three groups: group A (GrA)-30 patients with stable angina, mean age of 82.5 years, 24 (80) men; group B(GrB)-40 patients with unstable angina, mean age 81.2 years, 31 (77.5) men; group C (GrC)-27 patients with myocardial infarction (MI), mean age of 82 years, 16 (59.2) men. RESULTS: Early outcome-general success rate of 84.5 and mortality rate of 5.1. The success and mortality rate were in GrA 83.3 and 3.3, in GrB 85 and 5 and in GrC 85.2 and 7.4, respectively. Late outcome-the number and percentage of patients with late follow-up and the clinic-angiographic and angiographic restenosis rates were for GrA 19(76), 52.9, 75; GrB 30(88.2), 30.8, 61.5 and GrC 12(52.2), 66.6, 85.7, respectively. CONCLUSION: PTCA can be considered an important revascularization alternative in octogenarian patients because of high early success rate, low mortality and acceptable long-term outcome.
Subject(s)
Humans , Male , Female , Aged , Angina Pectoris , Angioplasty, Balloon, Coronary , Myocardial Infarction/therapy , Aged, 80 and over , Follow-Up StudiesABSTRACT
Objetivo - Mostrar a experiência do Instituto de Cardiologia do Rio Grande do Sul/Fundaçäo Universitária de Cardiologia, com angioplastia transluminal coronária (ATC), após uso de trombolítico no infarto agudo do miocárdio (IAM). Métodos - De 1984-1989, 193 pacientes foram tratados com estreptoquinase e, destes, 54 foram submetidos à ATC. A idade média foi de 50 anos e a maioria dos pacientes era do sexo masculino. A área predominante do IAM foi a parede anterior. A artéria coronária "culpada" mais freqüente foi a descendente anterior. A indicaçäo para ATC foi lesäo uniarterial com menos de 20 mm de extensäo. Resultados - Obteve-se sucesso imediato em 44 pacientes (81,5%). Dez pacientes foram considerados insucessos sendo seis enviados à cirurgia de revascularizaçäo miocárdica de urgência. O índice de infarto pós ATC na fase hospitalar foi de 5,5%. No seguimento tardio observou-se um índice de reestenose de 11% e reoclusäo de 3,7%, sendo necessária uma nova ATC em 3 pacientes (5,5) e cirurgia de revascularizaçäo em um (1,8%). Conclusäo - Conclui-se que a ATC é um mêtodo seguro e importante na complementaçäo terapêutica pós uso de droga trombolítica com baixa morbidade e mortalidade
Purpose - To presente the Cardiology Institute of Rio Grande do Sul experience with percutaneous coronary angioplasty (PTCA). af ter thrombolitic therapy in acute myocardial infarction (AMI). Methods - Fifty-three patients with transmural AMI in whom early successful intravenous streptokinase recanalization was followed by PTCA. The mean age WAS 50 years, male patients were more frequent, the predominant area of infarct was anterior wall and more frequently the culprit coronary was the left anterior descendent. The main indication of PTCA was uniarterial lesion with less than 20 mm of length. Results - The success comes out in 44 patients (81.5%). Ten patients (18,5%) were considered unsuccessful and were referred to emergency bypass graft surgery. The in-hospital AMI rate after PTCA was 5.5%. In the follow-up the reestenose rate was 11% and reocclusion was 3.7%. New PTCA was necessary in 3 patients (5.5%) and in one, by-pass graft (1,8%). Conclusion - PTCA is an important and secure modality of complementary therapy after thrombolitic therapy with low mortality and mortality